This observational study is following people with Experience of treatment within a psychiatric inpatient unit or Mental and Behavioural Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at care and outcomes for people with Mental and behavioural disorders: schizophrenia and other psychoses, depression, anxiety, neuroses, Mental and Behavioural Disorders, or Schizophrenia. Taking part may give some people access to 1, but direct benefit is not guaranteed.
In United Kingdom
Schizophrenia, Depression, ...Other
Countries
United Kingdom
Sponsor
NHS R&D Regional Programme Register - Department of Health (UK)
This study is looking at whether The intervention to be assessed is a complex psychological intervention comprising four related elements: 1 can help people with Topic: Critical Care, Mental Health, Subtopic: Critical Care, Anxiety, Disease: All Critical care, Anxiety, or Mental and Behavioural Disorders. Participants take part in The intervention to be assessed is a complex psychological intervention comprising four related elements: 1 and complete follow-up assessments.
In United Kingdom
AnxietyOtherOver 18 Years
Countries
United Kingdom
Sponsor
Intensive Care National Audit & Research Centre (UK)
This study is looking at whether 1 can help people with Topic: Mental Health, Critical care, Subtopic: Anxiety, Critical care, Disease: Anxiety, All Critical care, or Mental and Behavioural Disorders. Participants take part in 1 and complete follow-up assessments.
This study is looking at whether a digital support tool can help people with SCHIZOPHRENIA 1, Schizotypal Disorder, or Post Traumatic Stress Symptoms. Participants receive a study treatment and complete follow-up visits and assessments.
This study is comparing Psilocybin and Psilocyn with placebo for people with depression. Participants receive Psilocybin and Psilocyn or placebo and complete study visits and assessments.
In Foz do Iguaçu
DepressionDrugA study involving a medication or substance.From 25 Years to 65 Years
This study is looking at whether Two doses of psilocybin 10mg and 25mg per so, separated by one week can help people with Major depression, Mental and Behavioural Disorders, or Depression. Participants receive a study treatment and complete follow-up visits and assessments.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.